4//SEC Filing
Doshi Dipal 4
Accession 0001689375-24-000030
CIK 0001689375other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 5:21 PM ET
Size
6.3 KB
Accession
0001689375-24-000030
Insider Transaction Report
Form 4
Doshi Dipal
DirectorCEO
Transactions
- Sale
Common Stock
2024-05-17$15.11/sh−1,200$18,129→ 337,375 total - Sale
Common Stock
2024-05-16$15.00/sh−1,800$27,000→ 338,575 total
Footnotes (1)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023.
Documents
Issuer
Entrada Therapeutics, Inc.
CIK 0001689375
Entity typeother
Related Parties
1- filerCIK 0001613084
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 5:21 PM ET
- Size
- 6.3 KB